Department of Psychology, Bar Ilan University, Ramat Gan, Israel.
Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Int J Soc Psychiatry. 2022 May;68(3):589-599. doi: 10.1177/0020764021992385. Epub 2021 Feb 2.
As many patients view conventional antidepressants and anxiolytics negatively, it is not surprising that the willingness to apply these treatments is far from ideal, thus posing a critical barrier in promoting an effective and durable treatment.
The present study aimed to explore patients' attitudes toward conventional and herbal treatments for depression and anxiety, while considering cultural and demographic factors, to further elucidate the antecedes that putatively determine the treatment's outcome.
During June 2017, a cross-sectional survey was conducted using stratified sampling from a large-scale Israeli volunteer online panel. The final sample included 591 Jewish Israeli adults that reported they were suffering from depression or anxiety.
A heterogeneous range of attitudes toward treatment was found: for example, a large group of patients did not utilize prescription medications (39%), a professional consultation (12.9%), or any form of treatment (17.4%). Interestingly, these patients were significantly more likely to support naturally-derived treatments and were less concerned with scientific proof. Further, adverse effects were demonstrated as a prominent factor in the choice of treatment. A higher incidence of adverse effects was associated with an increased willingness to consider an alternative herbal treatment. Noteworthy attitudes were found in orthodox-Jewish individuals, who showed similar consultation rates, but utilized more psychological, rather than pharmacological treatments.
It is proposed that patients' perspectives and cultural backgrounds are needed to be taken into consideration during the clinical assessment and choice of treatment. The findings imply that a particular emphasis should be placed on patients that discard conventional pharmacological options and on distinct cultural aspects. Several recommendations for revising the current policy are advocated to promote more culturally-informed and patient-oriented care.
由于许多患者对传统抗抑郁药和抗焦虑药持负面看法,因此他们对应用这些治疗方法的意愿远非理想,这就构成了促进有效和持久治疗的关键障碍。
本研究旨在探讨患者对传统和草药治疗抑郁症和焦虑症的态度,并考虑文化和人口统计学因素,以进一步阐明可能决定治疗结果的因素。
2017 年 6 月,采用分层抽样法,从一个大型以色列志愿者在线小组中进行了横断面调查。最终样本包括 591 名报告患有抑郁症或焦虑症的犹太以色列成年人。
发现了对治疗的态度存在广泛的差异:例如,很大一部分患者没有使用处方药物(39%)、专业咨询(12.9%)或任何形式的治疗(17.4%)。有趣的是,这些患者更倾向于支持天然来源的治疗方法,并且不太关注科学证据。此外,不良反应被证明是治疗选择的一个突出因素。更多的不良反应与增加考虑替代草药治疗的意愿有关。在正统派犹太教个体中发现了值得注意的态度,他们表现出相似的咨询率,但更多地使用心理治疗,而不是药物治疗。
建议在临床评估和治疗选择中考虑患者的观点和文化背景。研究结果表明,应特别关注那些摒弃传统药物治疗方案的患者,以及不同的文化方面。为了促进更具文化意识和以患者为中心的护理,提出了几项修改当前政策的建议。